Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Trading Update

19 Jun 2020 12:15

RNS Number : 5329Q
Chamberlin PLC
19 June 2020
 

19 June 2020

Chamberlin plc

("Chamberlin" or the "Company")

 

Trading Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and engineering group, is pleased to provide a trading update following the announcement on 27 March 2020. 

 

The Company announces that the Walsall foundry reopened for production on 4 May 2020 following a three week closure. The machine shop, which also closed in April, has also reopened for production. While production levels at the Walsall factory are broadly in line with activity seen immediately prior to the impact from Covid-19, output levels at the Machine Shop are running at approximately 30% of that achieved before the COVID-19 measures.

 

Russell Ductile, the Company's Scunthorpe foundry operation, has remained open throughout and continues to operate at full production levels in response to customer demand. 

 

Petrel, Chamberlin's specialist lighting business has also remained open. However, due to suspension of a number of government and defence contracts, Petrel is operating at around 60% of normal sales volumes.

 

The health and safety of Chamberlin's employees has been, and remains, paramount. All operations are performed in line with relevant government guidelines and industry best practice specific to COVID-19 precautions. To date there have been no reported instances of any Chamberlin employee contracting COVID-19.

 

Chamberlin has taken advantage of the UK Government's measures to support business, including the furloughing of staff during the closure of the Walsall sites. The majority of employees are working normally with approximately 18% of the Company's workforce still furloughed.

 

Despite current levels of activity in the Walsall foundry being relatively high, the outlook for a number of the key markets, particularly across the automotive sector, remain uncertain. As a result, Chamberlin has taken steps to reduce costs in line with the expected reduction in demand.

 

Recognising the ongoing uncertainty across global markets, the Board continues to believe that it is too early to make any reasonable estimate of the financial impact on the Group during the current year and beyond.

 

The Company anticipates that the preliminary results for the year to 31 March 2020 will be announced in August 2020.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

 

Enquiries

 

Chamberlin plc

Kevin Nolan, Chief Executive

Neil Davies, Finance Director

 

T: 01922 707100

 

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Russell Cook

Katy Birkin

 

T: 020 7397 8900

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGPUWUQUPUGGB
Date   Source Headline
11th Mar 20215:21 pmRNSHolding(s) in Company
10th Mar 202110:41 amRNSHolding(s) in Company
10th Mar 202110:38 amRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
8th Mar 20211:30 pmRNSResult of Meeting and Directorate Change
19th Feb 20217:00 amRNSConvertible Loan and Notice of General Meeting
21st Jan 20217:00 amRNSTrading Statement
4th Jan 20217:30 amRNSSuspension - Chamberlin Plc
18th Dec 20205:43 pmRNSPublication of Audited Accounts
16th Dec 202011:55 amRNSTrading Update
27th Nov 20207:00 amRNSPublication of Audited Accounts
24th Nov 20207:15 amEQSHardman & Co Research: Chamberlin (CMH): Trading update ‒ main businesses performing solidly
23rd Nov 20207:00 amRNSTrading Update
6th Nov 20207:00 amRNSPublication of Audited Accounts
29th Sep 202010:42 amEQSHardman & Co Research: Chamberlin (CMH): Trading update most encouraging
29th Sep 20207:00 amRNSPublication of 2020 Accounts and Trading Update
23rd Jul 20205:48 pmRNSHolding(s) in Company
19th Jun 202012:15 pmRNSTrading Update
30th Mar 202012:45 pmEQSHardman & Co Research: Chamberlin Plc (CMH): Trading stalled in these unprecedented times
27th Mar 20202:24 pmRNSTrading Update
18th Feb 20203:20 pmRNSHolding(s) in Company
17th Feb 20202:00 pmRNSHolding(s) in Company
17th Feb 202011:52 amEQSHardman & Co Research: Chamberlin Plc (CMH): Near-term trading subdued
13th Feb 20205:53 pmRNSTrading Statement
6th Dec 20197:01 amRNSContract award for Walsall foundry
6th Dec 20197:00 amRNSContract award for Scunthorpe foundry
22nd Nov 20197:00 amRNSHolding(s) in Company
19th Nov 201911:55 amEQSHardman & Co Research: Chamberlin Plc (CMH): Management actions yield cautious optimism
18th Nov 20197:00 amRNSHalf-year Report
4th Nov 20197:00 amRNSNotice of Interim Results
21st Oct 20191:01 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSHolding(s) in Company
23rd Jul 20194:05 pmRNSResult of AGM
23rd Jul 20197:00 amRNSBoard Retirement
23rd Jul 20197:00 amRNSAGM Statement
19th Jun 201910:14 amRNSHolding(s) in Company
4th Jun 20197:31 amEQSHardman & Co Research: Chamberlin (CMH): Trading remains difficult; forecasts lowered
4th Jun 20197:00 amRNSFinal Results
30th May 201912:35 pmRNSTrading Update
21st Feb 20192:23 pmRNSHolding(s) in Company
6th Feb 20192:06 pmEQSHardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered
5th Feb 20197:52 amRNSTrading Update
24th Dec 20187:00 amRNSHalf-year Report
20th Dec 20187:00 amRNSSale of Exidor Limited
12th Dec 20187:00 amRNSChange of Adviser
12th Nov 20187:00 amRNSAppointment of Finance Director
2nd Aug 20187:00 amRNSDirectorate Change
24th Jul 20182:57 pmRNSResult of AGM
24th Jul 20187:00 amRNSAGM Statement
19th Jun 20183:39 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.